Anette E. Schrag

UCL Queen Square Institute Of Neurology
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Placebo-controlled three-armed pilot trial of Escitalopram or Nortriptyline for depressive symptoms in Parkinson's disease (ADepT-PD).

Placebo-controlled three-armed pilot trial of Escitalopram or Nortriptyline for depressive symptoms in Parkinson's disease (ADepT-PD).

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: February 26, 2026

Methods to detect anxiety in Parkinsons' disease.

Methods to detect anxiety in Parkinsons' disease.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: June 12, 2025

Corrigendum to "Quick MSA-QoL: A validated, abbreviated health-related quality of life questionnaire for use in Multiple System Atrophy" [Park. Relat. Disord. (2024) 128 107143. doi: 10.1016/j.parkreldis.2024.107143].

Corrigendum to "Quick MSA-QoL: A validated, abbreviated health-related quality of life questionnaire for use in Multiple System Atrophy" [Park. Relat. Disord. (2024) 128 107143. doi: 10.1016/j.parkreldis.2024.107143].

Journal: Parkinsonism & related disorders

Published: May 06, 2025

The barriers to receiving health care for people with Parkinson's from predominantly Asian backgrounds in the UK.

The barriers to receiving health care for people with Parkinson's from predominantly Asian backgrounds in the UK.

Journal: NPJ Parkinson's disease

Published: September 11, 2024

Impaired reward sensitivity in Parkinson's depression is unresponsive to dopamine treatment.

Impaired reward sensitivity in Parkinson's depression is unresponsive to dopamine treatment.

Journal: Brain : a journal of neurology

Published: July 26, 2024

Quick MSA-QoL: A validated, abbreviated health-related quality of life questionnaire for use in Multiple System Atrophy.

Quick MSA-QoL: A validated, abbreviated health-related quality of life questionnaire for use in Multiple System Atrophy.

Journal: Parkinsonism & related disorders

Published: June 12, 2024

Factors associated with self-rated health in people with late-stage parkinson's and cognitive impairment.

Factors associated with self-rated health in people with late-stage parkinson's and cognitive impairment.

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Published: May 28, 2024

Support needs of people with Multiple System Atrophy.

Support needs of people with Multiple System Atrophy.

Journal: Parkinsonism & related disorders

Published: November 07, 2023

Delivering the diagnosis of Parkinson's disease- setting the stage with hope and compassion.

Delivering the diagnosis of Parkinson's disease- setting the stage with hope and compassion.

Journal: Parkinsonism & related disorders

Published: September 28, 2023

Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson disease.

Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson disease.

Journal: Nature. Mental health

Published: July 27, 2023

Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson's disease.

Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson's disease.

Journal: medRxiv : the preprint server for health sciences

Published: July 10, 2023

Longitudinal decline in striatal dopamine transporter binding in Parkinson's disease: associations with apathy and anhedonia.

Longitudinal decline in striatal dopamine transporter binding in Parkinson's disease: associations with apathy and anhedonia.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: November 21, 2022

Showing 1-12 of 43

Last Updated: 09/26/2026